[Federal Register Volume 78, Number 106 (Monday, June 3, 2013)]
[Notices]
[Pages 33098-33099]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12967]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Co-Exclusive Licenses: Multi-Focal
Structured Illumination Microscopy Systems and Methods
AGENCY: National Institutes of Health, HHS.
[[Page 33099]]
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH),
Department of Health and Human Services, is contemplating the grant of
co-exclusive worldwide licenses to practice the inventions embodied in:
E-005-2012/0, /1, /2; U.S. Provisional Patent Application 61/602,139
filed February 23, 2012, U.S. Provisional Patent Application 61/732,460
filed December 3, 2012, and International Patent Application PCT/
US2013/27413 filed February 22, 2013 to Andor Technology PLC. having a
principle place of business in Belfast, Northern Ireland, and to
Vutara, Inc. having a principle place of business in Salt Lake City,
Utah.
The United States of America is an assignee to the patent rights of
these inventions.
The contemplated co-exclusive license may be in a field of use
directed to microscopy devices and systems.
DATES: Only written comments and/or applications for a license that are
received by the NIH Office of Technology Transfer on or before August
2, 2013 will be considered.
ADDRESSES: Requests for a copy of the patent application, inquiries,
comments and other materials relating to the contemplated license
should be directed to: Michael Shmilovich, Esq., CLP, Senior Licensing
and Patent Manager, Office of Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-
3804; Telephone: (301) 435-5019; Facsimile: (301) 402-0220; Email:
[email protected]. A signed confidential disclosure agreement may be
required to receive copies of the patent application assuming it has
not already been published under either the publication rules of either
the U.S. Patent and Trademark Office or World Intellectual Property
Organization.
SUPPLEMENTARY INFORMATION: The invention pertains to a system and
method for digital confocal microscopy that rapidly processes enhanced
images. In particular, the invention is a method for digital confocal
microscopy that includes a digital mirror device or a swept-field
confocal unit to produce a plurality of excitation foci that are imaged
to resulting emissions from a sample mounted on a conventional
microscope onto an array detector. Computer software detects each
confocal spot and provides two times the image resolution of the
diffraction limit. In addition, the software implements an optical
sectioning technique using a variable ``digital'' pinhole for each
confocal spot. Since the variable pinhole is digital (e.g., created by
the software), there is no loss in image signal due to additional
optical arrangements and tightly closed pinholes used in conventional
confocal microscopes.
The prospective co-exclusive licenses will be royalty-bearing and
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
The prospective co-exclusive license may be granted unless, within 60
days from the date of this published notice, NIH receives written
evidence and argument that establishes that the grant of the license
would not be consistent with the requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Properly filed competing applications for a license filed in
response to this notice will be treated as objections to the
contemplated license. Comments and objections submitted in response to
this notice will not be made available for public inspection, and, to
the extent permitted by law, will not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: May 28, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development and Transfer, Office of
Technology Transfer, National Institutes of Health.
[FR Doc. 2013-12967 Filed 5-31-13; 8:45 am]
BILLING CODE 4140-01-P